Shares of Willis Towers Watson Public Limited Company WTW have gained 4.8% in the past year, outperforming its industry’s decline of 27.4%.
The insurer has a market capitalization of $31.43 billion. The average volume of shares traded in the last three months was 0.6 million.
Image Source: Zacks Investment Research
Willis Towers’ bottom line surpassed earnings estimates in three of the last four quarters and missed in one, the average being 2.39%.
WTW shares are trading above the 200-day moving average, indicating a bearish trend.
Image Source: Zacks Investment Research
WTW Shares are Affordable
WTW shares are trading at a discount compared with the Zacks Brokerage Insurance industry. Its forward price-to-earnings multiple of 17.49X is lower than the industry average of 2.14X, the Finance sector’s 17.07X and the Zacks S&P 500 Composite’s 23.46X.
Shares of other insurers like Marsh & McLennan Companies, Inc. MMC and Arthur J. Gallagher & Co. AJG are trading at a multiple higher than the industry average, while Brown & Brown, Inc. BRO is trading at a discount.
Image Source: Zacks Investment Research
WTW’s Growth Projection Encourages
The Zacks Consensus Estimate for Willis Towers’ 2026 earnings per share and revenues indicates an increase of 13.9% and 4.8%, respectively, from the corresponding 2025 estimates.
Average Target Price for WTW Suggests Upside
Based on short-term price targets offered by 19 analysts, the Zacks average price target is $366.68 per share. The average suggests a potential 14.4% upside from the last closing price.
Image Source: Zacks Investment Research
Optimist Analyst Sentiment on WTW
One of the 10 analysts covering the stock has raised estimates for 2025, while two analysts have raised the same for 2026 over the past 30 days. The Zacks Consensus Estimate for 2025 earnings has moved up 0.2% in the past 30 days, while the same for 2026 has moved north 0.3% in the same time frame.
Factors Impacting WTW
Willis Towers’ growth strategy encompasses a focus on improving operating margins, increasing free cash flow conversion and driving sustainable revenue growth. Focus on core opportunities with the highest growth and return, which include gaining market share in Risk and Broking and Individual Marketplace, should spur long-term growth and return more value to shareholders.
Well-performing Health, Wealth & Career and Risk & Broking segments, driven by solid customer retention levels, growing new business and geographic diversification, continue to fuel the top line. Most of the company's operating regions experienced revenue growth for 15 straight quarters.
Strategic acquisitions have expanded its geographical footprint in the last few years in countries like Italy, Canada, the United Kingdom and France, as well as ramped up its product portfolio.
Willis Towers has been improving its liquidity while maintaining a solid balance sheet. A solid balance sheet and steady cash flow are expected to help the company engage in capital deployment for buybacks, dividend payouts, debt repayments, acquisitions and investments that drive and support growth.
Distribution of Wealth
Banking on its capital position, WTW distributes wealth to shareholders in the form of dividend hikes and share repurchases. Its dividend has witnessed a six-year CAGR (2019-2025) of 5.7%. The insurer continues to expect to allocate approximately $1.5 billion to share repurchases in 2025.
Headwinds
Despite the upside potential, Willis Towers’ expenses have been rising over the last several quarters. Higher salaries and benefits, other operating expenses, transaction and transformation, and increased consulting and compensation costs related to the Transformation program result in the contraction of margins. Willis Towers estimates to deliver an expansion in margin over the long term.
WTW’s trailing 12-month ROE of 21.4% is weak when compared with the industry average of 23.3%, reflecting its inefficiency in using shareholders' funds.
End Notes
Willis Towers boasts a strong product portfolio and has a solid track record of strategic acquisitions, as well as favorable growth estimates. The Health, Wealth & Career and Risk & Broking segments should continue to witness significant growth from increases in most lines of business. A robust capital position over the years reflects its financial flexibility.
Given the escalating expenses and poor return on equity, it is better to stay cautious about this Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Naming Top 10 Stocks for 2026
Want to be tipped off early to our 10 top picks for the entirety of 2026? History suggests their performance could be sensational.
From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.
Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2026. Don’t miss your chance to get in on these stocks when they’re released on January 5.
Be First to New Top 10 Stocks >>Marsh & McLennan Companies, Inc. (MMC) : Free Stock Analysis Report
Arthur J. Gallagher & Co. (AJG) : Free Stock Analysis Report
Brown & Brown, Inc. (BRO) : Free Stock Analysis Report
Willis Towers Watson Public Limited Company (WTW) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
